Chemed
420 hedge funds and large institutions have $7.12B invested in Chemed in 2021 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 121 increasing their positions, 155 reducing their positions, and 43 closing their positions.
51% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 43
9% more capital invested
Capital invested by funds: $6.5B → $7.12B (+$614M)
4% more funds holding
Funds holding: 403 → 420 (+17)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.9% less ownership
Funds ownership: 88.92% → 88.02% (-0.9%)
17% less call options, than puts
Call options by funds: $8.94M | Put options by funds: $10.8M
22% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 155
Top Buyers
Top Sellers
CHE Hedge Fund Activity: Q4 2021 in Review
420 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2021, worth a combined $7.12B — up 9.5% from $6.5B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new CHE positions and 43 closed out — a net gain of 22 holders — while 121 added to existing stakes and 155 trimmed.
The largest buyer was Fidelity International, adding an estimated $67.2M. The largest seller was Wells Fargo, cutting an estimated $134M.
- 420 institutional investors held Chemed (CHE) as of Q4 2021, up from 403 in Q3 2021.
- Funds reported $7.12B of Chemed stock for Q4 2021, up 9.5% quarter-over-quarter.
- 65 funds opened new Chemed positions in Q4 2021 and 43 closed out, a net change of +22 holders.
- The largest Chemed buyer in Q4 2021 was Fidelity International, an estimated $67.2M added.
- The largest Chemed seller in Q4 2021 was Wells Fargo, an estimated $134M sold.
Based on aggregated 13F filings for Q4 2021.